Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Azitra, Inc. (AZTR) vs XTL Biopharmaceuticals Ltd. (XTLB)

Azitra, Inc. and XTL Biopharmaceuticals Ltd. are both Biotechnology companies. Azitra, Inc. and XTL Biopharmaceuticals Ltd. are of similar size ($10.1M and $9.7M). XTL Biopharmaceuticals Ltd. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −12.7%. Across the 13 metrics below, XTL Biopharmaceuticals Ltd. leads on 7 and Azitra, Inc. on 6.

Valuation

Metric AZTR XTLB Biotechnology median
P/E 2.54 n/m 7.88
P/S 5.66 1.53 11.47
P/B 0.45 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.31 n/m 0.74
EV/Sales (5.94) 1.44 10.73
Earnings yield 39.35% (12.73%) (28.84%)
Free cash flow yield (346.99%) (124.05%) (23.03%)

Profitability

Metric AZTR XTLB Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) 0.00% (57.72%)
Return on assets (190.69%) 0.00% (49.22%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR XTLB Biotechnology median
Revenue growth (TTM) 58.18% (12.71%) 5.64%
EPS growth (last fiscal year) 85.67% (159.17%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR XTLB Biotechnology median
Debt to equity 0.00 (1.83) 0.00
Current ratio 4.86 0.70 4.73
Net debt to EBITDA 0.20 (0.11) 0.96

Dividend

Metric AZTR XTLB Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric AZTR XTLB Biotechnology median
Market cap 10.10m 9.66m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack